Your browser doesn't support javascript.
loading
Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.
Shino, Michael Y; Li, Ning; Todd, Jamie L; Neely, Megan L; Kirchner, Jerry; Kopetskie, Heather; Sever, Michelle L; Frankel, Courtney W; Snyder, Laurie D; Pavlisko, Elizabeth N; Martinu, Tereza; Singer, Lianne G; Tsuang, Wayne; Budev, Marie; Shah, Pali D; Reynolds, John M; Williams, Nikki; Robien, Mark A; Palmer, Scott M; Sam Weigt, Stephen; Belperio, John A.
Afiliação
  • Shino MY; Division of Pulmonary and Critical Care Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Li N; Division of Pulmonary and Critical Care Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Todd JL; Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA.
  • Neely ML; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
  • Kirchner J; Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Kopetskie H; Rho Federal Systems Division, Rho, Durham, NC, USA.
  • Sever ML; Rho Federal Systems Division, Rho, Durham, NC, USA.
  • Frankel CW; Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA.
  • Snyder LD; Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA.
  • Pavlisko EN; Department of Pathology, Duke University Medical Center, Durham, NC, USA.
  • Martinu T; Division of Respirology, University Health Network, University of Toronto, Ontario, Canada.
  • Singer LG; Division of Respirology, University Health Network, University of Toronto, Ontario, Canada.
  • Tsuang W; Respiratory Institute/Division of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Budev M; Respiratory Institute/Division of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Shah PD; Division of Pulmonary and Critical Care Medicine, John Hopkins University, Baltimore, MD, USA.
  • Reynolds JM; Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA.
  • Williams N; Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Robien MA; Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Palmer SM; Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA.
  • Sam Weigt S; Division of Pulmonary and Critical Care Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Belperio JA; Division of Pulmonary and Critical Care Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Am J Transplant ; 21(10): 3401-3410, 2021 10.
Article em En | MEDLINE | ID: mdl-33840162
ABSTRACT
The histopathologic diagnosis of acute allograft injury is prognostically important in lung transplantation with evidence demonstrating a strong and consistent association between acute rejection (AR), acute lung injury (ALI), and the subsequent development of chronic lung allograft dysfunction (CLAD). The pathogenesis of these allograft injuries, however, remains poorly understood. CXCL9 and CXCL10 are CXC chemokines induced by interferon-γ and act as potent chemoattractants of mononuclear cells. We hypothesized that these chemokines are involved in the mononuclear cell recruitment associated with AR and ALI. We further hypothesized that the increased activity of these chemokines could be quantified as increased levels in the bronchoalveolar lavage fluid. In this prospective multicenter study, we evaluate the incidence of histopathologic allograft injury development during the first-year post-transplant and measure bronchoalveolar CXCL9 and CXCL10 levels at the time of the biopsy. In multivariable models, CXCL9 levels were 1.7-fold and 2.1-fold higher during AR and ALI compared with "normal" biopsies without histopathology. Similarly, CXCL10 levels were 1.6-fold and 2.2-fold higher during these histopathologies, respectively. These findings support the association of CXCL9 and CXCL10 with episodes of AR and ALI and provide potential insight into the pathogenesis of these deleterious events.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimiocina CXCL10 / Rejeição de Enxerto Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimiocina CXCL10 / Rejeição de Enxerto Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos